Ravi Anand

A PET Study of the Pathophysiology of Negative Symptoms in Schizophrenia

Steven G. Potkin, Gustavo Alva, Kirsten Fleming et al. · American Journal of Psychiatry · 2002 · 198 citations

Medicine, Neuroscience, Psychiatry +17

A Study of the Pharmacokinetic Properties and the In Vivo Kinetics of Erythrocytes Loaded With Dexamethasone Sodium Phosphate in Healthy Volunteers

Shodeinde Coker, Zbigniew M. Szczepiorkowski, Alan Siegel et al. · Transfusion Medicine Reviews · 2017 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +5

The International Suicide Prevention Trial (InterSePT): Rationale and Design of a Trial Comparing the Relative Ability of Clozapine and Olanzapine To Reduce Suicidal Behavior in Schizophrenia and Schizoaffective Patients

Larry Alphs, Ravi Anand, MA Islam et al. · Schizophrenia Bulletin · 2004 · 41 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Tolerability, Safety and Pharmacokinetics of the FGLL Peptide, a Novel Mimetic of Neural Cell Adhesion Molecule, Following Intranasal Administration in Healthy Volunteers

Ravi Anand, Michael Seiberling, Thierry Kamtchoua et al. · Clinical Pharmacokinetics · 2007 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase 2 Results Indicate Evenamide, A Selective Modulator of Glutamate Release, Is Associated With Clinically Important Long-Term Efficacy When Added to an Antipsychotic in Patients With Treatment-Resistant Schizophrenia

Ravi Anand, Alessio Turolla, Giovanni Chinellato et al. · The International Journal of Neuropsychopharmacology · 2023 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17